0001610717-24-000189.txt : 20240328 0001610717-24-000189.hdr.sgml : 20240328 20240328161158 ACCESSION NUMBER: 0001610717-24-000189 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240327 FILED AS OF DATE: 20240328 DATE AS OF CHANGE: 20240328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cislini Jeff CENTRAL INDEX KEY: 0001969082 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39219 FILM NUMBER: 24799026 MAIL ADDRESS: STREET 1: C/O REVOLUTION MEDICINES, INC. STREET 2: 700 SAGINAW DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Revolution Medicines, Inc. CENTRAL INDEX KEY: 0001628171 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 472029180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 700 SAGINAW DR CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 415-766-3638 MAIL ADDRESS: STREET 1: 700 SAGINAW DR CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 form4.xml X0508 4 2024-03-27 0001628171 Revolution Medicines, Inc. RVMD 0001969082 Cislini Jeff C/O REVOLUTION MEDICINES, INC. 700 SAGINAW DRIVE REDWOOD CITY CA 94063 true General Counsel true Common Stock 2024-03-27 4 S 0 700 30.3843 D 55174 D Common Stock 2024-03-27 4 S 0 800 31.515 D 54374 D Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 27, 2023. This transaction was executed in multiple trades in prices ranging from $30.16 to $30.85, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Includes 48,972 restricted stock units. This transaction was executed in multiple trades in prices ranging from $31.38 to $31.68, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. /s/ Jack Anders, as Attorney-in-fact for Jeff Cislini 2024-03-28